Mariam Faragalla

Mariam Faragalla has a strong background in finance and accounting, with experience in both the biotech and pharmaceutical industries. Mariam is currently working as a Senior Director & Controller at Rivus Pharmaceuticals since January 2023. Prior to that, they served as a Biotech and Pharmaceutical Accounting Consultant for Consulting Services starting in May 2021.

From March 2020 to May 2021, Mariam worked as the Vice President of Finance and Administration at Plant Response Inc. Before that, they held the position of Senior Director Finance Capital Projects & Corporate Affairs at Amicus Therapeutics from January 2019 to February 2020.

Mariam has also held senior finance roles, including Vice President of Finance and Operations at Scioderm, Inc., a company acquired by Amicus Therapeutics in September 2015. Mariam served in this role from May 2013 to January 2019. Prior to that, they were the Corporate Controller at CoLucid Pharmaceuticals, Inc from February 2009 to June 2013.

Notably, Mariam has experience as a Life Sciences Consultant for start-up and development stage companies, working in this capacity from April 2008 to May 2013. Mariam also served as a Corporate Controller at Serenex, Inc. from February 2004 to September 2008.

Mariam began their career as a CPA at various CPA firms, working from December 1991 to February 1998. Mariam also has experience as an Assistant Controller at Inveresk Research from 2000 to 2003.

Mariam Faragalla has studied at Baruch College, where they pursued a Bachelor of Business Administration (BBA) degree with a specialization in Accounting. The exact start and end years of their education are not provided.